长春瑞滨为主联合方案治疗39例中晚期非小细胞肺癌  

Effect of combined chemotherapy including Navelbine in the treatment of 39 cases of advanced non-small cell lung cancer

作　　者：潘小杰[1] 欧德彬[1] 吴榕龙[1] 

机构地区：[1]福建省立医院肿瘤科,福建福州350001

出　　处：《中国癌症杂志》2002年第2期176-177,共2页China Oncology

摘　　要：目的 :观察长春瑞滨 (NVB)治疗中晚期非小细胞肺癌的疗效。方法 :用长春瑞滨为主的联合方案治疗39例 (初治 30例 ,复治 9例 )Ⅲ～Ⅳ期非小细胞肺癌 ,并观察其毒副反应。结果 :完全缓解 (CR) 2例 ,部分缓解 (PR)2 0例 ,稳定 (NC) 13例 ,进展 (PD) 4例 ,总有效率 5 6 4 % ,主要毒副作用为骨髓抑制。结论 :NVB为主联合化疗对中晚期非小细胞肺癌疗效较好 。Purpose:To study the effect of NVB in the treatment of advanced non small cell lung cancer (NSCLC).Methods:In 39 cases advanced stage, primary chemotherapy patients account for 30 cases and 9 were recurrent diseases.Results:CR 2 cases PR 20 cases NC 13 cases and PD 4 cases, total response rate 56.4%. The majory toxicity was bone marrow suppression.Conclusions:Combined chemotherapy including NVB has better curative effect for advanced NSCLC.

关 键 词：长春瑞滨 中晚期非小细胞肺癌 联合化疗 

分 类 号：R734.2[医药卫生—肿瘤] R730.53[医药卫生—临床医学]